Jon Jones ‘B’ Sample Fails

Share

In what may be the end of one of the most brilliant and conflicted careers in the history, Jon Jones ‘B’ sample has come back positive.

The ‘B’ sample taken from Jones was from his in-competition collection July 28 in for his fight at UFC 214 against Daniel Cormier for the light heavyweight title, came back positive Tuesday for Turinabol. The performance enhancer mainly seen in cattle is the same substance that Jones tested positive for in the ‘A’ sample.

“Mr. Jones’ B sample has confirmed the A sample findings,” USADA said in a statement through a spokesperson. “Importantly — as previously stated — due process should occur before drawing any conclusions about this matter.”

With the ‘B’ sample confirming the positive test, Jones will now begin his adjudication process with USADA, the UFC’s anti-doping partner. It is not certain how long this process will take as Jones will also have a disciplinary hearing on October 17th in front of the California State Athletic Commission, which also has jurisdiction in the case.

Jones is facing up to a four-year suspension from USADA, since he is a repeat offender. Last year, he tested positive for the banned substances clomiphene and Letrozol and was handed a one-year suspension.

Arbitrators ruled in 2016 that Jones was reckless in taking a sexual-enhancement pill that was contaminated with the two substances. Once again, with this latest test failure, Jones’ team is saying he ingested the steroid unknowingly, possibly via a tainted supplement.

Pending the USADA adjudication process. Jones’ victory of Cormier is likely to be overturned into a no contest by CSAC.